A Brazilian makeup artist and influencer, Roseli Fernandes de Oliveira Romeiro Vieira, has tragically passed away at the age of 48, following complications from a cosmetic surgery procedure. She succumbed to her injuries on May 26, a day after undergoing buttock augmentation surgery that involved the use of polymethylmethacrylate (PMMA), a dermal filler not approved for aesthetic enhancement in Brazil.
:max_bytes(150000):strip_icc():format(jpeg)/roseli-fernandes-1-052826-98c6a10d48f3474c974450ca2ac96037.jpg)
Reports from local media outlets, including G1, CNN Brasil, and Metrópoles, indicate that Fernandes began suffering severe pain shortly after the procedure. Her daughter reported to police that her condition deteriorated rapidly, prompting a call to her doctor. Sadly, during her transit to the clinic, Fernandes lost consciousness in a ride-share vehicle.

Upon arrival at the clinic, surveillance footage captured the moments when emergency responders attempted to help Fernandes. She was carried from the vehicle in a wheelchair, yet remained unresponsive despite multiple attempts to revive her. Shortly thereafter, the medical team at the clinic confirmed her passing.

Investigators from the Civil Police are treating the incident as suspicious and have launched a formal inquiry. The investigation will examine the circumstances surrounding her death, particularly focusing on the clinical practices employed by her physician, Dr Tábita Nunes Marcolino Jorge. Reports suggest that he performed the injection without holding a residency in dermatology, raising questions about the appropriateness of the procedures administered.
Fernandes reportedly spent more than 54,000 Brazilian reais, equivalent to over £10,000, on her aesthetic treatments. While her passing has sparked concern and mourning among her followers—numbering at least 100,000 across various social media platforms—significant questions remain regarding the safety protocols and legal standards governing cosmetic surgeries in Brazil.
In response to the unfolding investigation, Dr Jorge’s legal representation has claimed there is no evidence directly linking the medical procedure to Fernandes’s death. They have stated that the doctor willingly provided a statement to authorities and is cooperating fully with the Civil Police.
The Brazilian National Health Surveillance Agency has previously mandated that PMMA can only be used for restorative medical treatments, not cosmetic surgery. This points to a potential breach of regulatory oversight, which has garnered the attention of health officials and the public alike.
In a time of grief, Dr Jorge expressed her condolences to Fernandes’s family, reiterating her desire for transparency in the investigation. However, the lack of clear regulatory guidance surrounding cosmetic surgery practices continues to fuel concern over patient safety and the legitimacy of such procedures in Brazil.
As inquiries continue, the loss of Roseli Fernandes de Oliveira Romeiro Vieira serves as a poignant reminder of the risks associated with cosmetic surgery. The case raises critical issues regarding the need for stricter regulations and monitoring of aesthetic medical practices in an industry known for its rapid growth and appeal. Until more comprehensive answers are provided, the tragic circumstances of her demise will remain at the forefront of discussions concerning patient safety in Brazil’s cosmetic surgery sector.
